Skip to main content
logo
Nidan Laboratories and Healthcare Limited (NSE:NIDAN)
India flag India · Delayed Price · Currency is INR
13.45
+0.30 (2.28%)
Jul 31, 2026, 12:49 PM IST

NSE:NIDAN Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
255.42255.42245.28241.77242.66296.6
Revenue Growth
-5.80%4.13%1.45%-0.36%-18.19%42.65%
Gross Profit
245.42245.42225.74219.84217.99258.9
Operating Income
29.4529.4528.2235.7837.0567.83
Net Income
15.0615.0619.77-32.3235.426.63
Earnings Per Share
1.081.081.42-2.332.552.32
EPS Growth
-34.96%-23.94%--9.76%-0.24%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
19.9519.9518.9928.584.1981.01
Total Debt
111.64111.64111.11124.35109.3192.95
Net Cash (Debt)
-91.69-91.69-92.11-95.85-25.11-111.93
Net Cash Growth
------
Net Cash Per Share
-6.58-6.58-6.63-6.90-1.81-9.76

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
16.6716.6722.7655.2109.6978.28
Capital Expenditures
-4.77-4.77-9.4-7.36-6.68-70.74
Free Cash Flow
11.911.913.3647.84103.017.53
Free Cash Flow Growth
-35.06%-10.91%-72.07%-53.56%1267.61%-38.16%

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
96.08%96.08%92.04%90.93%89.83%87.29%
Operating Margin
11.53%11.53%11.50%14.80%15.27%22.87%
Pretax Margin
9.57%9.57%11.25%-9.80%19.83%15.24%
Profit Margin
5.90%5.90%8.06%-13.37%14.59%8.98%
FCF Margin
4.66%4.66%5.45%19.79%42.45%2.54%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
12.4511.7711.64-13.2917.33
P/FCF Ratio
15.7114.8917.227.864.5761.27
PS Ratio
0.730.690.941.561.941.56